<DOC>
	<DOCNO>NCT02007577</DOCNO>
	<brief_summary>The possibility obesity-associated inflammatory change may play role pathogenesis type 2 diabetes ( 2DM ) lead increase interest possibility salicylate might represent useful treatment improve glucose tolerance . Several study , perform patient 2DM , well nondiabetic , obese individual , demonstrate salicylate beneficial effect glucose insulin metabolism , lead coherent view mechanism ( ) involve . In research proposal use specific method quantify insulin mediate glucose uptake ( IMGU ) , glucose-stimulated insulin secretion rate ( GS-ISR ) , insulin clearance ( I-Cl ) overweight/obese , nondiabetic , insulin resistant individual . We use insulin suppression test ( IST ) quantify IMGU nondiabetic , overweight/obese volunteer identify individual sufficiently insulin resistant enrol study . We use grade glucose infusion technique insulin resistant subject generate specific measure GS-IS I-Cl . Following baseline measurement , salsalate placebo administer one month participant , time IST grade glucose infusion repeat quantify compare change IMGU , GS-ISR , I-Cl result salsalate versus placebo . These result provide first time quantitative data effect salicylates IMGU , GS-ISR , I-Cl overweight/obese , insulin resistant , nondiabetic individual .</brief_summary>
	<brief_title>Beneficial Effect Salicylates : Insulin Action , Secretion Clearance ?</brief_title>
	<detailed_description />
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Salicylsalicylic acid</mesh_term>
	<mesh_term>Sodium Salicylate</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<criteria>Healthy volunteer , BMI 2535kg/m2 , Without severe anemia , kidney , liver disease current GI ulcer bleed Or medication contraindicate salsalate Recent history GI bleed ulcer , CVD anticoagulant Severe kidney liver disease Allergies aspirin Taking aspirin anti inflammatory medication regular basis take duration study</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>insulin resistant</keyword>
</DOC>